Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla

Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla

Saved in:

Bibliographic Details
Main Authors:	Amy N Courtney, Gengwen Tian, Leonid S Metelitsa, Andras Heczey
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/3/e011858.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhancing the physiological characteristics of chimeric antigen receptor natural killer cells by synthetic biology
by: Shuochao Ji, et al.
Published: (2025-04-01)

Neutrophilic hyperleukocytosis in the multiple myeloma onset
by: I. G. Rekhtina, et al.
Published: (2022-07-01)

Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.
by: Christin Eger, et al.
Published: (2016-01-01)

Effects of Mesenchymal Stem Cells on Functions of Chimeric Antigen Receptor-Expressing T Lymphocytes and Natural Killer Cells
by: Vladislav Volarevic, et al.
Published: (2025-06-01)

GD2 targeting CAR T cells for neuroblastoma
by: John Anderson, et al.
Published: (2024-12-01)

Hyperleukocytosis in a neonate: A diagnostic dilemma
by: Sushanth, et al.
Published: (2010-01-01)

Criminalização do bullying e do cyberbulliyng: o Estado penal ataca novamente
by: Helena Zani Morgado
Published: (2024-03-01)

Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
by: Wangshu Li, et al.
Published: (2024-12-01)

Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
by: Julien Fleurence, et al.
Published: (2017-01-01)

Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells
by: Taha B. Hayal, et al.
Published: (2025-06-01)

Therapeutic Leukapheresis in Acute Leukaemia with Hyperleukocytosis: A Series of Three Cases
by: G Kavinkumar, et al.
Published: (2025-07-01)

Near-infrared photoimmunotherapy using antiGD2 antibody for neuroblastoma and osteosarcoma
by: Jimei Zhao, et al.
Published: (2025-06-01)

Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
by: Sudjit Luanpitpong, et al.
Published: (2021-01-01)

Dual-labeled anti-GD2 targeted probe for intraoperative molecular imaging of neuroblastoma
by: Lauren Taylor Rosenblum, et al.
Published: (2024-10-01)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma
by: Jourdin R. C. Rouaen, et al.
Published: (2024-12-01)

Hyperleukocytosis, leukemoid reaction caused by malignant peritoneal mesothelioma: a case report and review of literature
by: Kaibo Zhu, et al.
Published: (2025-05-01)

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors.
by: Hannah Karlsson, et al.
Published: (2015-01-01)

Advance in chimeric antigen receptor T therapy in autoimmune diseases
by: Xiaolan Ji, et al.
Published: (2025-03-01)

Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
by: Qin Liu, et al.
Published: (2024-03-01)

GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout
by: Wiebke Jünemann, et al.
Published: (2025-05-01)

Debulking Therapy with Obinutuzumab Is Helpful and Safe in Chronic Lymphocytic Leukemia with Extreme Hyperleukocytosis: A Case Report
by: Dario Leotta, et al.
Published: (2025-03-01)

The potential of chimeric antigen receptor -T cell therapy for endocrine cancer
by: Ruonan Yu, et al.
Published: (2025-04-01)

Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy
by: Jia-Hui Liu, et al.
Published: (2025-05-01)

Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters
by: Hyung Bae Park, et al.
Published: (2024-11-01)

An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers.
by: Simon Thomas, et al.
Published: (2016-01-01)

Impact of Pre‐Examination Video Education in Gd‐EOB‐DTPA‐Enhanced Liver MRI: Correspondence
by: Hinpetch Daungsupawong, et al.
Published: (2025-06-01)

Chimeric antigen receptor–engineered T cells for liver cancers, progress and obstacles
by: Keyu Li, et al.
Published: (2017-03-01)

Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation
by: Shaomei Feng, et al.
Published: (2025-06-01)

Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy
by: C. Carcopino, et al.
Published: (2024-12-01)

Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T‐Cell Therapy
by: Jia Yi Tan, et al.
Published: (2025-03-01)

Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs
by: Guo-Fen Re, et al.
Published: (2022-10-01)

Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
by: Haiqiong Zheng, et al.
Published: (2024-11-01)

Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy
by: Francesca Sillito, et al.
Published: (2025-04-01)

Revolutionizing Allogeneic Graft Tolerance Through Chimeric Antigen Receptor-T Regulatory Cells
by: Alvin Man Lung Chan, et al.
Published: (2025-07-01)

Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
by: Yong Liu, et al.
Published: (2025-07-01)

MUC18-Directed chimeric antigen receptor T cells for the treatment of mucosal melanoma
by: Fenghao Zhang, et al.
Published: (2025-04-01)

Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
by: Mingwei Jiang, et al.
Published: (2025-12-01)

Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species
by: Cynthia J. Siebrand, et al.
Published: (2025-05-01)

Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells
by: Pengju Wang, et al.
Published: (2025-01-01)